In conclusion, we found that among the three T cell subsets evaluated, only the CD45RO+ T cell density was significantly associated with longer survival in CRC patients, independent of tumor stage, lymphovascular invasion, and CD8+ and FOXP3+ T cell densities. The gene discussed is FOXP3; the disease is neoplasm.